Futu News, September 12th: Hong Kong's major stock indexes rose across the board. As of the time of publication, the Hang Seng Index rose 0.91%, the Hang Seng China Enterprises Index rose 0.76%, and the Hang Seng Tech Index rose 1.49%.
In terms of sectors, technology stocks performed strongly, with Meituan up over 4%, Bilibili and JD.com up over 3%, and Alibaba, Netease, Baidu, and Kuaishou up over 2%.
The concept of contract research organizations continued to rise, with WuXi AppTec and WuXi Biologics up over 4%, Asymchem Laboratories and Tigermed up over 3%.
Macau casino stocks rose, with Melco Int'l Dev up over 3% and Galaxy Entertainment and Sands China Ltd up over 2%.
Mainland property management stocks performed weakly, with Jinke Services and Colour Life down over 8%, and Yongsheng Services, Binjiang Services, and Wanwu Cloud down over 1%.
Mainland education stocks declined, with Tianli Int Hldg down over 12%, Chuanglian Hold down 12%, and Xijiao Int Hldg down over 2%.
Building materials and cement stocks rose across the board, with Conch Cement and Huaxin Cement up over 3%, CNBM, Shanshui Cement, and Westchinacement up over 2%.
In terms of individual stocks, $STARPLUS LEGEND (06683.HK)$ Rose more than 32%, fell more than 72% yesterday. The company's announcement confirmed that business operations remain normal.
$CMGE (00302.HK)$ Rose more than 4%, the company fully acquired the global intellectual property rights of "Chinese Paladin".
$BRILLIANCE CHI (01114.HK)$ Dropped by more than 8%, Citigroup lowered the target price of Brilliance China to 4.42 Hong Kong dollars, and also lowered the net profit forecast.
$INNOVENT BIO (01801.HK)$ Rose more than 2%, Citigroup initiated a 90-day upward catalyst observation period for Innovent Bio, with a target price of 62 Hong Kong dollars.
Editor/Jeffy